Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Capsaicin + allyl isothiocyanate is a combination of two small molecule compounds, each with distinct bioactive properties. **Capsaicin** is a potent agonist of the transient receptor potential vanilloid 1 (**TRPV1**) ion channel, predominantly found in sensory neurons, and induces a burning pain sensation followed by desensitization to painful stimuli. Capsaicin’s activation of TRPV1 triggers downstream pathways involving protein kinases (e.g., PKA, PKC, MAPK), increases neuropeptide (such as CG). Allyl isothiocyanate is known to activate the transient receptor potential ankyrin 1 (TRPA1) channel, also involved in nociception and inflammatory responses.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on capsaicin + allyl isothiocyanate.